Andere Sprachen IM Cannabis Corp.

Aktien

A3DZ0R

CA44969Q3070

IMCC

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 19:11:08 26.04.2024			% 5 Tage	% 1. Jan.
0,78 ^CAD	0,00 %		-1,27 %	+69,57 %

09.04.	IM Cannabis Corp. und Vessel Brand, Inc. arbeiten zusammen, um Vessel Cannabiszubehör auf den israelischen Markt zu bringen	CI
04.04.	IM Cannabis und Avant Brands unterzeichnen Lizenzvertrag für BLK MKT für den deutschen Markt für medizinisches Cannabis	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

IM Cannabis Corp. and Vessel Brand, Inc. Partner to Bring Vessel Cannabis Accessories to the Israeli Market	09.04.
IM Cannabis, Avant Brands Sign BLK MKT's Licensing Deal for German Medical Cannabis Market	04.04.
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	04.04.
IM Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25.03.
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25.03.
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25.03.
IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis	25.03.
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06.03.
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	28.02.
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company	28.02.
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.	28.02.
Avant Brands Brief: Restructuring Loan Agreements to Extend Term and Decrease Payments	26.02.
IM Cannabis Brief: Says Received 180 Calendar Day Extension from Nasdaq Stock Market to Regain Compliance with Bid Price Rule	31.01.
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition	15.01.
IM Cannabis Rescheduling Final Payment of the Oranim Pharmacy Acquisition	12.01.
IM Cannabis Announced Conclusion of Planning and Construction Legal Proceedings Against Focus Medical	02.01.
IM Cannabis Notes New Israeli Cannabis Regulation Delayed by Three Months	08.12.
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	07.12.
IM Cannabis : REPORT OF VOTING RESULTS - Form 6-K	07.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen IM Cannabis Corp.

Aktien

A3DZ0R

CA44969Q3070

IMCC

Andere Sprachen

Filter